Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Structural Insights for Anti-Influenza Vaccine Design. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
Unresolved reference
1957 · External reference
Unresolved reference
1968 · External reference
HNRNPA2B1 is a mediator of m(6)A-dependent nuclear RNA processing events
10.1016/j.cell.2015.08.011 · 2015 · External reference
Preferential induction of cross-group influenza A hemagglutinin stem-specific memory B cells after H7N9 immunization in humans
10.1126/sciimmunol.aan2676 · 2017 · External reference
Novel chitosan wound dressing loaded with minocycline for the treatment of severe burn wounds
10.1016/j.ijpharm.2006.09.016 · 2007 · External reference
10.1371/journal.ppat.1004103
10.1371/journal.ppat.1004103 · External reference
10.1038/s41467-018-04704-9
10.1038/s41467-018-04704-9 · External reference
10.1128/aac.02457-15
10.1128/aac.02457-15 · External reference
An antibody that prevents the hemagglutinin low pH fusogenic transition
10.1006/viro.2001.1320 · 2002 · External reference
10.1073/pnas.1810927115
10.1073/pnas.1810927115 · External reference
10.1128/jvi.03152-15
10.1128/jvi.03152-15 · External reference
Structural insight into a human neutralizing antibody against influenza virus H7N9
10.1128/jvi.01850-17 · 2018 · External reference
Broad neutralizing activity of a human monoclonal antibody against H7N9 strains from 2013 to 2017
10.1038/s41426-018-0182-2 · 2018 · External reference
High throughput discovery of influenza virus neutralizing antibodies from phage-displayed synthetic antibody libraries
10.1038/s41598-017-14823-w · 2017 · External reference
Broad cross-protection against H5N1 avian influenza virus infection by means of monoclonal antibodies that map to conserved viral epitopes
10.1086/594374 · 2009 · External reference
Human monoclonal antibodies targeting the haemagglutinin glycoprotein can neutralize H7N9 influenza virus
10.1038/ncomms7714 · 2015 · External reference
10.1038/nature23912
10.1038/nature23912 · External reference
10.1056/nejmoa0907650
10.1056/nejmoa0907650 · External reference
10.1126/science.1205669
10.1126/science.1205669 · External reference
10.1080/21645515.2015.1012013
10.1080/21645515.2015.1012013 · External reference
10.1128/jvi.02975-12
10.1128/jvi.02975-12 · External reference
10.1126/science.1222908
10.1126/science.1222908 · External reference
Antibody recognition of a highly conserved influenza virus epitope
10.1126/science.1171491 · 2009 · External reference
10.1126/science.1204839
10.1126/science.1204839 · External reference
10.1038/nature11414
10.1038/nature11414 · External reference
10.1126/science.1202617
10.1126/science.1202617 · External reference
10.1128/jvi.79.5.2814-2822.2005
10.1128/jvi.79.5.2814-2822.2005 · External reference
New class of monoclonal antibodies against severe influenza: prophylactic and therapeutic efficacy in ferrets
10.1371/journal.pone.0009106 · 2010 · External reference
10.1073/pnas.1319058110
10.1073/pnas.1319058110 · External reference
10.1126/science.1093155
10.1126/science.1093155 · External reference
Influenza, an existing public health problem
2006 · External reference
10.1128/cvi.05533-11
10.1128/cvi.05533-11 · External reference
10.1016/j.vaccine.2011.01.100
10.1016/j.vaccine.2011.01.100 · External reference
10.1128/jvi.79.17.11533-11536.2005
10.1128/jvi.79.17.11533-11536.2005 · External reference
10.1016/0042-6822(83)90465-8
10.1016/0042-6822(83)90465-8 · External reference
10.1056/nejmoa0907413
10.1056/nejmoa0907413 · External reference
Preclinical pharmacokinetics of MHAA4549A, a human monoclonal antibody to influenza A virus, and the prediction of its efficacious clinical dose for the treatment of patients hospitalized with influenza A
10.1080/19420862.2016.1167294 · 2016 · External reference
10.1073/pnas.201401198
10.1073/pnas.201401198 · External reference
10.1128/jvi.00137-12
10.1128/jvi.00137-12 · External reference
10.1126/science.1062882
10.1126/science.1062882 · External reference
Rapidly produced SAM((R)) vaccine against H7N9 influenza is immunogenic in mice
2013 · External reference
10.1016/j.imbio.2017.10.040
10.1016/j.imbio.2017.10.040 · External reference
10.1128/jvi.01388-13
10.1128/jvi.01388-13 · External reference
10.1038/nrmicro1208
10.1038/nrmicro1208 · External reference
10.1128/jvi.06665-11
10.1128/jvi.06665-11 · External reference
Structure-function analysis of neutralizing antibodies to H7N9 influenza from naturally infected humans
10.1038/s41564-018-0303-7 · 2019 · External reference
10.1126/science.aac7263
10.1126/science.aac7263 · External reference
10.1016/j.cell.2016.06.043
10.1016/j.cell.2016.06.043 · External reference
10.1126/science.aan0516
10.1126/science.aan0516 · External reference
10.1016/j.cell.2016.05.073
10.1016/j.cell.2016.05.073 · External reference
Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies
10.1073/pnas.0801367105 · 2008 · External reference
10.1371/journal.ppat.1000990
10.1371/journal.ppat.1000990 · External reference
10.1371/journal.pone.0011548
10.1371/journal.pone.0011548 · External reference
10.1111/j.1365-2567.2006.02421.x
10.1111/j.1365-2567.2006.02421.x · External reference
10.1371/journal.ppat.1005409
10.1371/journal.ppat.1005409 · External reference
10.1111/irv.12446
10.1111/irv.12446 · External reference
10.1128/jvi.02184-09
10.1128/jvi.02184-09 · External reference
The use of antibodies in the prophylaxis and treatment of infections
2012 · External reference
10.1016/j.celrep.2017.08.084
10.1016/j.celrep.2017.08.084 · External reference
Potency of a recombinant NDV-H5 vaccine against various HPAI H5N1 virus challenges in SPF chickens
10.1637/10173-041012-resnote.1 · 2012 · External reference
10.1126/science.aaq0620
10.1126/science.aaq0620 · External reference
10.1016/j.antiviral.2013.03.021
10.1016/j.antiviral.2013.03.021 · External reference
10.1016/0042-6822(69)90132-9
10.1016/0042-6822(69)90132-9 · External reference
10.1038/ncomms4614
10.1038/ncomms4614 · External reference
Structural characterization of viral epitopes recognized by broadly cross-reactive antibodies
2015 · External reference
10.1073/pnas.1212371109
10.1073/pnas.1212371109 · External reference
Two phase 1, randomized, double-blind, placebo-controlled, single-ascending-dose studies to investigate the safety, tolerability, and pharmacokinetics of an anti-influenza A virus monoclonal antibody, MHAA4549A, in healthy volunteers
10.1128/aac.00607-16 · 2016 · External reference
10.1073/pnas.1218841110
10.1073/pnas.1218841110 · External reference
10.1016/j.jmb.2017.05.011
10.1016/j.jmb.2017.05.011 · External reference
Genetics, pathogenicity and transmissibility of novel reassortant H5N6 highly pathogenic avian influenza viruses first isolated from migratory birds in western China
2018 · External reference
10.1016/j.biologicals.2017.08.007
10.1016/j.biologicals.2017.08.007 · External reference
Phase 2 randomized trial of the safety and efficacy of MHAA4549A, a broadly neutralizing monoclonal antibody, in a human influenza A virus challenge model
10.1128/aac.01154-17 · 2017 · External reference
10.1016/j.immuni.2017.12.009
10.1016/j.immuni.2017.12.009 · External reference
10.1016/j.antiviral.2016.01.012
10.1016/j.antiviral.2016.01.012 · External reference
10.1038/nature03063
10.1038/nature03063 · External reference
Broadly reactive human monoclonal antibodies elicited following pandemic H1N1 influenza virus exposure protect mice against highly pathogenic H5N1 challenge
10.1128/jvi.00949-18 · 2018 · External reference
10.1016/j.chom.2013.06.004
10.1016/j.chom.2013.06.004 · External reference
10.1128/jvi.05397-11
10.1128/jvi.05397-11 · External reference
10.1128/jvi.67.5.2552-2558.1993
10.1128/jvi.67.5.2552-2558.1993 · External reference
10.1038/nature13764
10.1038/nature13764 · External reference
The geography and mortality of the 1918 influenza pandemic
1991 · External reference
10.1073/pnas.1715471115
10.1073/pnas.1715471115 · External reference
10.1021/bi00155a013
10.1021/bi00155a013 · External reference
Towards a universal influenza vaccine: different approaches for one goal
10.1186/s12985-017-0918-y · 2018 · External reference
10.1016/j.cell.2015.04.028
10.1016/j.cell.2015.04.028 · External reference
10.1073/pnas.1218256109
10.1073/pnas.1218256109 · External reference
10.1007/s12275-013-2399-z
10.1007/s12275-013-2399-z · External reference
Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza
10.1371/journal.pmed.0040178 · 2007 · External reference
10.1146/annurev.biochem.69.1.531
10.1146/annurev.biochem.69.1.531 · External reference
Prevention and treatment of bronchopneumonia in mice caused by mouse-adapted variant of avian H5N2 influenza A virus using monoclonal antibody against conserved epitope in the HA stem region
10.1007/s007050070088 · 2000 · External reference
10.1126/science.1097211
10.1126/science.1097211 · External reference
A virus obtained from influenza patients
10.1016/s0140-6736(00)78541-2 · 1995 · External reference
10.1038/nbt.3907
10.1038/nbt.3907 · External reference
10.1038/nri2054
10.1038/nri2054 · External reference
10.1038/nsmb.1566
10.1038/nsmb.1566 · External reference
10.1371/journal.pone.0005476
10.1371/journal.pone.0005476 · External reference
10.3201/eid1209.05-0979
10.3201/eid1209.05-0979 · External reference
10.1016/j.chom.2014.04.009
10.1016/j.chom.2014.04.009 · External reference
10.1073/pnas.1502374112
10.1073/pnas.1502374112 · External reference
10.1172/jci85317
10.1172/jci85317 · External reference
10.1371/journal.pone.0003942
10.1371/journal.pone.0003942 · External reference
10.1371/journal.ppat.1003657
10.1371/journal.ppat.1003657 · External reference
10.1126/science.1136212
10.1126/science.1136212 · External reference
10.1371/journal.pbio.3000139
10.1371/journal.pbio.3000139 · External reference
10.1038/srep22666
10.1038/srep22666 · External reference
10.1073/pnas.0813172106
10.1073/pnas.0813172106 · External reference
Human antibody 3E1 targets the HA stem region of H1N1 and H5N6 influenza A viruses
10.1038/ncomms13577 · 2016 · External reference
10.1038/333426a0
10.1038/333426a0 · External reference
10.1038/nbt.2214
10.1038/nbt.2214 · External reference
10.1073/pnas.1111497108
10.1073/pnas.1111497108 · External reference
10.1038/289373a0
10.1038/289373a0 · External reference
10.1038/289366a0
10.1038/289366a0 · External reference
10.1016/j.vaccine.2015.05.038
10.1016/j.vaccine.2015.05.038 · External reference
10.1016/j.ebiom.2016.02.021
10.1016/j.ebiom.2016.02.021 · External reference
Computationally optimized broadly reactive Hemagglutinin elicits Hemagglutination inhibition antibodies against a panel of H3N2 influenza virus Cocirculating variants
2017 · External reference
10.1084/jem.20101352
10.1084/jem.20101352 · External reference
10.1016/j.jmb.2017.06.015
10.1016/j.jmb.2017.06.015 · External reference
10.1016/j.chom.2017.05.011
10.1016/j.chom.2017.05.011 · External reference
10.1038/ncomms8708
10.1038/ncomms8708 · External reference
10.1128/jvi.00178-14
10.1128/jvi.00178-14 · External reference
10.1371/journal.ppat.1001081
10.1371/journal.ppat.1001081 · External reference
10.1371/journal.ppat.1000350
10.1371/journal.ppat.1000350 · External reference
10.1038/nature07231
10.1038/nature07231 · External reference
10.1080/13543784.2017.1269170
10.1080/13543784.2017.1269170 · External reference
10.1038/ncomms9855
10.1038/ncomms9855 · External reference
